Skip to content

Treatment of painful menstruation - ayurveda

A clinical study of Kashtartava and its management by Hingvashtaka churna and Erand bhrushta haritaki Sunthi churna

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/04/008296
Enrollment
40
Registered
2017-04-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients suffering from dysmenorrhoea(Kashtartava) more than 3 cycles

Interventions

Intervention1: HINGVASHTAKA CHURNA: 3gms twice a day with luke warm water, Intervention2: Hingvashtaka Churna: Bhaishjya Ratnavali,Prof. Sidhhinandan Mishra, Agnimandhya Adhyaya (10), page no. 342 3g

Sponsors

Parul Institute Of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients coming with chief complaint of painful menses 2)Age between 16 to 25 yrs 3)Patients suffering from dysmenorrhoea more than 3 cycles.

Exclusion criteria

Exclusion criteria: 1)Patients below 15yrs and above 25yrs 2)Patients having congenital anomalies leading to dysmenorrhoea 3)Patients on hormonal therapy and Oral Contraceptive pills 4)Patients having Any uterine pathology like fibroid, adenomyosis, endometriosis. 5)Patients is suffering from Acute infections, menorrhagia

Design outcomes

Primary

MeasureTime frame
1.Pain reduction in Kashtartava by by using VMS- Verbal multidimensional scoring system. 2.Changes in Haematological parameters. 3.Improvement in associated symptoms like Alpaartava, Prasek, Chhardi, Vibhandha, Shrama, Aruchi, Vankshana Shoola, Kati-Janu Shoola. 4.For subjective parameters especially on Ayurvedic parlance suitable scoring pattern shall be developed.Timepoint: all outcome will be observed every month. and final outcome will be observed after 2 months of administration of medicines

Secondary

MeasureTime frame
The total effect of the therapy will be assessed considering to the overall improvement in signs and symptoms. For this purpose, following categories will be maintained. 1.Complete remission: 76%-100% relief in the signs and symptoms will be considered as complete resmission. 2.Marked improvement: 51%-75% relief in the signs and symptoms. 3.Improved: 26%-50% relief 4.Unchanged:Below 25% relief.Timepoint: Follow up after 1 month during treatment and after completion of treatment for 2 cycles.

Countries

India

Contacts

Public ContactSamhita JThaker

Parul Institute Of Ayurveda

jyotsnabenmshah@gmail.com9427981338

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026